The most active component of grape seed extract, B2G2, induces the cell death known as apoptosis in prostate cancer cells while leaving healthy cells unharmed, according to a new study.
Researchers have discovered how prostate cancer stem cells evolve as the disease progresses, a...
A byproduct of cholesterol functions like the hormone estrogen to fuel the growth and spread of...
Women who are members of families with BRCA2 mutations but who test negative for the family-specific BRCA2 mutations are still at greater risk for developing breast cancer compared with women in the general population, according to a new study.
New findings show that eating a high-fat diet beginning at puberty speeds up the development of breast cancer and may actually increase the risk of cancer similar to a type often found in younger adult women.
A novel immune-boosting drug combination eradicates glioblastoma brain cancer in mice, according to a new study.
A team of scientists looking into the interplay of the immune system and cancer have found a link between a history of airborne allergies– in particular to plants, grass and trees– with risk of blood cancers in women.
Cancers that occur in later life could be down to the way our cells age, according to a new paper that says some cancers could be caused by older cells bypassing the switch that tells them to stop growing.
Chemical engineers have developed a novel way to generate nanoparticles that can recognize specific molecules, opening up a new approach to building durable sensors for many different compounds.
Using Drosophila melanogaster, researchers discovered that during multiple cell migrations a single cell can act as leader, dragging the others with it.
The protein in cells that most often drives the development of cancers has eluded scientists’ efforts to block it for three decades– until now.
Help yourself to some nuts this holiday season: Regular nut eaters were less likely to die of cancer or heart disease — in fact, were less likely to die of any cause — during a 30-year Harvard study.
The deadliest brain cancer requires grueling treatment with bleak prospects for survival. Now, researchers have discovered a key component to how these aggressive tumors grow that could lead to better solutions.
Men with prostate cancer who ate a low-fat diet and took fish oil supplements had lower levels of pro-inflammatory substances in their blood and a lower cell cycle progression score— a measure used to predict cancer recurrence— than men who ate a typical Western diet, researchers found.
Scientists have discovered that the presence of a specific protein can distinguish between prostate cancers that are aggressive and need further treatment from those that may never seriously harm the patient.
Understanding how and why cancer cells move away from their original location is important to find ways to stop the spread of the disease. New findings reveal how a protein, called ‘PRH’, is normally able to prevent cells from unnecessary migration. It is likely that this protein is less effective in cancer cells allowing the cells to venture away.
Scientists have found that the immune system’s behavior can act as an early warning alarm that detects cancer recurrence, and this could offer a chance for pre-emptive treatment before the disease takes hold for the second time. The study, in mice, involved researchers looking for early signs of the immune response ‘kicking in’ indicating that the cancer was once more awake.
A new method to take the DNA fingerprint of individual cancer cells is uncovering the true extent of cancer’s genetic diversity, new research reveals. The technique can identify the founding mutations from which a tumor evolved and then uses computer software to draw a map of the cancer’s family tree.
Mutations in the genes that defend the body against cancer-related viruses and other infections may play a larger role in breast cancer than previously thought. A researcher looked at the DNA sequences of breast cancers from 21 different women and found mutations in genes involved in immunity in every one of them. The mutations were each different, but all would have affected some aspect of pathogen recognition and defense.
Researchers have developed a new technique for fighting deadly and hard-to-treat pancreatic cancer that uses two different types of nanoparticles, the first type clearing a path into tumor cells for the second, which delivers chemotherapy drugs.
Researchers studying how cancer spreads into bone have made a surprising discovery that suggests several investigational anti-cancer therapies just entering the drug-development pipeline may not have the desired effect.
Women vaccinated with one dose of a human papillomavirus (HPV) vaccine had antibodies against the viruses that remained stable in their blood for four years, suggesting that a single dose of vaccine may be sufficient to generate long-term immune responses and protection against new HPV infections, and ultimately cervical cancer.
Nitric oxide (NO) is one of the most important signaling molecules in living cells, carrying messages within the brain and coordinating immune system functions. In many cancerous cells, levels are perturbed, but very little is known about how NO behaves in both healthy and cancerous cells.
Tumors become highly malignant when they acquire the ability to colonize other tissues and form metastases. Ludwig-Maximilians-Universität München researchers have identified a factor that promotes metastasis of colon tumors – and presents a possible target for therapy.
Cisplatin is a chemotherapy drug given to more than half of all cancer patients. The drug kills cells very effectively, but tumors can become resistant to the drug and grow back. A new study offers a possible way to overcome that resistance.
Scientists have demonstrated that that cancer cells need a protein called Bod1 to grow and divide. When this protein is removed, cancer cells lose control of cell division and die.
A bone drug already on the market for osteoporosis may kill chronic myelogenous leukemia (CML) stem cells thought to persist in the bone marrow after standard therapy, lowering the likelihood of disease recurrence, according to a new study.
Research into clinical use of microbeam radiation therapy (MRT) has been limited because of the sheer size of the technology required to generate the beams. Now, researchers have developed a new microbeam emitter which has scaled down the technology, opening the doors for clinical research.
- Page 1